Comment on 'accelerated hypofractionated chemoradiation for locally advanced head and neck cancer during COVID-19 pandemic: A tertiary care experience'
J Cancer Res Ther
.
2024 Apr 1;20(3):1106-1107.
doi: 10.4103/jcrt.jcrt_367_24.
Epub 2024 Jun 27.
Authors
Efsun Somay
1
2
,
Erkan Topkan
3
,
Ugur Selek
4
,
Berrin Pehlivan
5
Affiliations
1
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, Ankara, Turkey.
2
Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Kyrenia University, Girne, Cyprus.
3
Department of Radiation Oncology, Faculty of Dentistry, Baskent University, Ankara, Turkey.
4
Department of Radiation Oncology, Faculty of Medicine, Koc University, Istanbul, Turkey.
5
Department of Radiation Oncology, Faculty of Medicine, Bahcesehir University, Istanbul, Turkey.
PMID:
39023628
DOI:
10.4103/jcrt.jcrt_367_24
No abstract available
Publication types
Letter
MeSH terms
COVID-19* / epidemiology
Chemoradiotherapy* / methods
Head and Neck Neoplasms* / therapy
Humans
Pandemics
Radiation Dose Hypofractionation*
SARS-CoV-2*
Tertiary Healthcare